Abstract

Regenerative medicine is emerging as a groundbreaking approach in the treatment of diabetes, with stem cell therapy at its forefront. Diabetes, a chronic condition characterized by impaired insulin production or action, has traditionally been managed through lifestyle changes, medication, and insulin therapy. However, these treatments do not address the underlying cause of the disease. Stem cells offer a promising alternative by potentially restoring normal pancreatic function. Research has focused on differentiating pluripotent stem cells into insulin-producing beta cells, which can be transplanted into patients to replenish their depleted cell populations. Recent advances have demonstrated significant progress in improving the efficiency and safety of these techniques. This review explores the current state of stem cell therapy in diabetes, highlighting key scientific breakthroughs, clinical trials, and future directions. By addressing both Type 1 and Type 2 diabetes, stem cell therapy holds the potential to revolutionize diabetes management, moving from symptom control to a potential cure. As this field progresses, it promises to offer new hope for millions of individuals affected by this debilitating disease.